Industry
Medical - Diagnostics & Research
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Loading...
Open
0.83
Mkt cap
29M
Volume
162K
High
0.92
P/E Ratio
-0.91
52-wk high
2.60
Low
0.80
Div yield
N/A
52-wk low
0.70
Portfolio Pulse from
November 09, 2024 | 5:45 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 6:52 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 12:33 pm
Portfolio Pulse from Avi Kapoor
September 13, 2024 | 9:49 am
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 10:10 am
Portfolio Pulse from Benzinga Newsdesk
July 16, 2024 | 12:32 pm
Portfolio Pulse from Benzinga Newsdesk
June 25, 2024 | 12:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.